Predict your next investment

HEALTHCARE | Drug Delivery
hylapharm.com

See what CB Insights has to offer

Stage

Unattributed - III | Alive

Total Raised

$1.1M

Last Raised

$300K | 6 yrs ago

About NanoPharm

NanoPharm, dba HylaPharm, has a novel drug-delivery technology that makes treatment of certain types of cancer, including breast cancer and head and neck cancer, both safer and more effective. Using their new delivery system, chemotherapy drugs can be given as a simple shot which is easier to administer than intravenous infusions, and can even be taken at home. Efficacy has already been demonstrated in animal models in numerous peer-reviewed scientific publications in top journals. Larger animal trials for submission to the US drug regulatory agency (FDA) are underway at Colorado State University Animal Cancer Center.

NanoPharm Headquarter Location

2029 Becker Dr

Lawrence, Kansas, 66047,

United States

785-371-0147

Latest NanoPharm News

Aptar Acquires Nanopharm and Gateway Analytical, for Approx. $50M

Jun 12, 2019

$50M Crystal Lake, Illinois-based AptarGroup, Inc. (NYSE: ATR) acquired Nanopharm Ltd. and Gateway Analytical LLC , two pharmaceutical services companies, for a combined enterprise value of approximately $50m. The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments. Both acquisitions bring complementary, value-added and differentiated analytical, testing and development services for all stages of drug development and commercialization. The expanded services platform will enable Aptar Pharma to collaborate earlier with customers to support their complex drug formulations and delivery requirements as they face increasingly competitive and regulated markets. Nanopharm, located in Newport, UK, is a science-driven provider of orally inhaled and nasal drug product design and development services. Gateway Analytical, located in Gibsonia, PA, provides particulate detection and predictive analytical services to customers developing injectable medicines. The companies’ results will be included in the Pharma segment and the transactions are not expected to be dilutive to Aptar’s earnings in 2019. Led by Gael Touya, President, and Stephan Tanda, President and CEO, Aptar is a global supplier of a broad range of innovative dispensing, sealing and active packaging solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. The company has over 14,000 dedicated employees in 18 different countries. FinSMEs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing NanoPharm

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NanoPharm is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

NanoPharm Patents

NanoPharm has filed 3 patents.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • ATC codes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/17/2020

11/23/2021

Pharmacokinetics, Dosage forms, ATC codes, Life sciences industry, Drug delivery devices

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/17/2020

00/00/0000

00/00/0000

Grant Date

11/23/2021

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Pharmacokinetics, Dosage forms, ATC codes, Life sciences industry, Drug delivery devices

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

NanoPharm Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NanoPharm Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.